Bromfed is NOT recommended for chest congestion from COVID-19 or influenza
There is no evidence supporting the use of Bromfed (brompheniramine/pseudoephedrine/dextromethorphan combination) for chest congestion due to COVID-19 or influenza, and it should not be used for this purpose.
Why Bromfed Is Not Appropriate
Confusion About "Bromfed" vs. Bromhexine
The available evidence addresses bromhexine (a mucolytic agent), which is an entirely different medication from Bromfed (an antihistamine/decongestant/cough suppressant combination). These are not interchangeable:
- Bromhexine: A mucolytic that may have TMPRSS2 inhibitory properties, studied in COVID-19 1, 2
- Bromfed: Contains brompheniramine (antihistamine), pseudoephedrine (decongestant), and dextromethorphan (cough suppressant) 3
Evidence Against Mucolytics in Respiratory Infections
Even for bromhexine (the mucolytic), the evidence is limited:
- A 2019 CHEST guideline found only one small RCT of bromhexine in pneumonia, which showed no improvement in cough outcomes (OR 1.21; 0.48-3.04) 4
- The 2006 ACCP guidelines concluded that bromhexine was inactive in modifying cough in three studies of chronic bronchitis, with benefit only in one larger study 5
- No major COVID-19 guidelines recommend mucolytics or expectorants for treatment 6
What the COVID-19 Research Actually Shows
While some recent studies suggest bromhexine may reduce ICU admission and mortality in COVID-19 2 and potentially reduce cough 7, these findings:
- Are from small, single-center trials requiring larger validation
- Apply only to bromhexine, not Bromfed
- Have not been incorporated into any major treatment guidelines 8, 6
Specific Concerns With Bromfed
The FDA label for Bromfed highlights important contraindications 3:
- Should be used with caution in patients with bronchial asthma (relevant given COVID-19 respiratory complications)
- Contains pseudoephedrine, which should be used cautiously with hypertension, heart disease, diabetes, and thyroid disease
- Common adverse effects include thickening of bronchial secretions, which could worsen chest congestion
- Contraindicated in nursing mothers and children under 6 months
What You Should Use Instead
For COVID-19 Chest Congestion:
- Supportive care remains the cornerstone 8, 6
- Oxygen supplementation if SpO2 < 92% 6
- Consider systemic corticosteroids if mechanically ventilated with ARDS 6
- No routine antibiotics unless bacterial co-infection suspected 9, 6
For Influenza:
- Antiviral therapy (oseltamivir, zanamivir) is the evidence-based treatment 4
- Symptomatic management with acetaminophen for fever 6
Key Clinical Pitfall
Do not confuse bromhexine (a mucolytic studied in COVID-19) with Bromfed (an over-the-counter cold medication). They are completely different drugs with different mechanisms and indications. Neither has established efficacy for chest congestion in COVID-19 or influenza based on current guidelines.